Search Results - "Mohammed Abdul Rasheed" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Safety, Tolerability, and Pharmacokinetics of Ropanicant (SUVN-911), a Novel Alpha4 Beta2 Nicotinic Acetylcholine Receptor (α4β2 nAChR) Antagonist, in Healthy Adult and Elderly Subjects

Safety, Tolerability, and Pharmacokinetics of Ropanicant (SUVN-911), a Novel Alpha4 Beta2 Nicotinic Acetylcholine Receptor (α4β2 nAChR) Antagonist, in Healthy Adult and Elderly Subjects

by Nirogi, Ramakrishna, Benade, Vijay, Goyal, Vinod Kumar, Pandey, Santosh Kumar, Mohammed, Abdul Rasheed, Shinde, Anil, Dogiparti, Dhanunjay, Ravula, Jyothsna, Jetta, Satish, Palacharla, Veera Raghava Chowdary
Published in Clinical drug investigation (01.09.2022)

Get full text

Journal Article

Wide-field choroidal vascular analysis in central serous chorioretinopathy

Wide-field choroidal vascular analysis in central serous chorioretinopathy

by Singh, Sumit Randhir, Invernizzi, Alessandro, Rasheed, Mohammed Abdul, Cagini, Carlo, Goud, Abhilash, Gujar, Ramkailash, Vupparaboina, Kiran Kumar, Ankireddy, Samatha, Cozzi, Mariano, Lupidi, Marco, Chablani, Jay
Published in European journal of ophthalmology (01.09.2021)

Get more information

Journal Article

Masupirdine (SUVN‐502): A promising clinical candidate for the management of agitation in Alzheimer’s dementia

Masupirdine (SUVN‐502): A promising clinical candidate for the management of agitation in Alzheimer’s dementia

by Nirogi, Ramakrishna, Jayarajan, Pradeep, Tadiparthi, Jayaprakash, Shinde, Anil K, Rasheed, Mohammed Abdul, Goyal, Vinod Kumar, Bhyrapuneni, Gopinadh, Benade, Vijay, Palacharla, Veera Raghava Chowdary, Ravula, Jyothsna, Jetta, Satish
Published in Alzheimer's & dementia (01.12.2021)

Get full text

Journal Article

SUVN‐D4010: A serotonin‐4 receptor partial agonist for the treatment of cognitive disorders

SUVN‐D4010: A serotonin‐4 receptor partial agonist for the treatment of cognitive disorders

by Medapati, Rajesh Babu, Ganuga, Narender, Mekala, Venkat Reddy, Bhyrapuneni, Gopinadh, Thentu, Jagadeesh Babu, Daripelli, Saivishal, Gagginapalli, Shankar Reddy, Bogaraju, Narsimha, Rasheed, Mohammed Abdul, Nirogi, Ramakrishna
Published in Alzheimer's & dementia (01.12.2021)

Get full text

Journal Article

Synthesis and SAR of Imidazo[1,5-a]pyridine derivatives as 5-HT4 receptor partial agonists for the treatment of cognitive disorders associated with Alzheimer's disease

Synthesis and SAR of Imidazo[1,5-a]pyridine derivatives as 5-HT4 receptor partial agonists for the treatment of cognitive disorders associated with Alzheimer's disease

by Nirogi, Ramakrishna, Mohammed, Abdul Rasheed, Shinde, Anil K., Bogaraju, Narsimha, Gagginapalli, Shankar Reddy, Ravella, Srinivasa Rao, Kota, Laxman, Bhyrapuneni, Gopinadh, Muddana, Nageswara Rao, Benade, Vijay, Palacharla, Raghava Chowdary, Jayarajan, Pradeep, Subramanian, Ramkumar, Goyal, Vinod Kumar
Published in European journal of medicinal chemistry (20.10.2015)

Get full text

Journal Article

Effects of Masupirdine (SUVN‐502) on Agitation/Aggression and Psychosis in Patients with Probable Alzheimer’s Disease: A Post Hoc Analysis

Effects of Masupirdine (SUVN‐502) on Agitation/Aggression and Psychosis in Patients with Probable Alzheimer’s Disease: A Post Hoc Analysis

by Nirogi, Ramakrishna, Jayarajan, Pradeep, Abraham, Renny, Tadiparthi, Jayaprakash, Benade, Vijay, Shinde, Anil K, Rasheed, Mohammed Abdul, Badange, Rajesh Kumar, Goyal, Vinod Kumar, Palacharla, Veera Raghava Chowdary, Ravulu, Jyothsna, Jetta, Satish, Subramanian, Ramkumar
Published in Alzheimer's & dementia (01.12.2022)

Get full text

Journal Article

Effect of Concurrent Use of Memantine on The Efficacy of Masupirdine (SUVN‐502): A Post‐hoc Analysis of a Phase‐2 Randomized Placebo‐Controlled Study

Effect of Concurrent Use of Memantine on The Efficacy of Masupirdine (SUVN‐502): A Post‐hoc Analysis of a Phase‐2 Randomized Placebo‐Controlled Study

by Goyal, Vinod Kumar, Pandey, Santosh Kumar, Benade, Vijay, Shinde, Anil K, Rasheed, Mohammed Abdul, Badange, Rajesh Kumar, Palacharla, Veera Raghava Chowdary, Ravulu, Jyothsna, Jetta, Satish, Subramanian, Ramkumar, Nirogi, Ramakrishna
Published in Alzheimer's & dementia (01.12.2022)

Get full text

Journal Article

Correlation of sectoral choroidal vascularity with angiographic leakage in central serous chorioretinopathy

Correlation of sectoral choroidal vascularity with angiographic leakage in central serous chorioretinopathy

by Singh, Sumit Randhir, Beale, Oliver, Nkrumah, Gideon, Rasheed, Mohammed Abdul, Sahoo, Niroj Kumar, Vupparaboina, Kiran Kumar, Tatti, Filippo, Chandra, Khushboo, Iovino, Claudio, Peiretti, Enrico, Chhablani, Jay
Published in European journal of ophthalmology (01.03.2022)

Get more information

Journal Article

Absorption, distribution, metabolism, excretion (ADME), drug-drug interaction potential and prediction of human pharmacokinetics of SUVN-G3031, a novel histamine 3 receptor (H3R) inverse agonist in clinical development for the treatment of narcolepsy

Absorption, distribution, metabolism, excretion (ADME), drug-drug interaction potential and prediction of human pharmacokinetics of SUVN-G3031, a novel histamine 3 receptor (H3R) inverse agonist in clinical development for the treatment of narcolepsy

by Nirogi, Ramakrishna, Bhyrapuneni, Gopinadh, Muddana, Nageswara Rao, Manoharan, Arunkumar, Shinde, Anil K, Mohammed, Abdul Rasheed, Padala, Nagasurya Prakash, Ajjala, Devender Reddy, Subramanian, Ramkumar, Palacharla, Veera Raghava Chowdary
Published in European journal of pharmaceutical sciences (01.09.2020)

Get full text

Journal Article

Synthesis, Structure-Activity Relationships, and Preclinical Evaluation of Heteroaromatic Amides and 1,3,4-Oxadiazole Derivatives as 5-HT 4 Receptor Partial Agonists

Synthesis, Structure-Activity Relationships, and Preclinical Evaluation of Heteroaromatic Amides and 1,3,4-Oxadiazole Derivatives as 5-HT 4 Receptor Partial Agonists

by Nirogi, Ramakrishna, Mohammed, Abdul Rasheed, Shinde, Anil K, Gagginapally, Shankar Reddy, Kancharla, Durga Malleshwari, Middekadi, Vanaja Reddy, Bogaraju, Narsimha, Ravella, Srinivasa Rao, Singh, Pooja, Birangal, Sumit Raosaheb, Subramanian, Ramkumar, Palacharla, Raghava Choudary, Benade, Vijay, Muddana, Nageswararao, Jayarajan, Pradeep
Published in Journal of medicinal chemistry (14.06.2018)

Get full text

Journal Article

Discovery and Development of 3‑(6-Chloropyridine-3-yloxymethyl)-2-azabicyclo[3.1.0]hexane Hydrochloride (SUVN-911): A Novel, Potent, Selective, and Orally Active Neuronal Nicotinic Acetylcholine α4β2 Receptor Antagonist for the Treatment of Depression

Discovery and Development of 3‑(6-Chloropyridine-3-yloxymethyl)-2-azabicyclo[3.1.0]hexane Hydrochloride (SUVN-911): A Novel, Potent, Selective, and Orally Active Neuronal Nicotinic Acetylcholine α4β2 Receptor Antagonist for the Treatment of Depression

by Nirogi, Ramakrishna, Mohammed, Abdul Rasheed, Shinde, Anil K, Ravella, Srinivasa Rao, Bogaraju, Narsimha, Subramanian, Ramkumar, Mekala, Venkat Reddy, Palacharla, Raghava Choudary, Muddana, Nageswararao, Thentu, Jagadeesh Babu, Bhyrapuneni, Gopinadh, Abraham, Renny, Jasti, Venkat
Published in Journal of medicinal chemistry (26.03.2020)

Get full text

Journal Article

First-in-Human Studies to Evaluate the Safety, Tolerability, and Pharmacokinetics of a Novel 5-HT4 Partial Agonist, SUVN-D4010, in Healthy Adult and Elderly Subjects

First-in-Human Studies to Evaluate the Safety, Tolerability, and Pharmacokinetics of a Novel 5-HT4 Partial Agonist, SUVN-D4010, in Healthy Adult and Elderly Subjects

by Nirogi, Ramakrishna, Bhyrapuneni, Gopinadh, Muddana, Nageswara Rao, Goyal, Vinod Kumar, Pandey, Santosh Kumar, Mohammed, Abdul Rasheed, Ravula, Jyothsna, Jetta, Satish, Palacharla, Veera Raghava Chowdary
Published in Clinical drug investigation (01.05.2021)

Get full text

Journal Article

Masupirdine (SUVN‐502) in combination with donepezil and memantine in moderate Alzheimer's disease: Effect of AD duration since diagnosis and patient’s age on efficacy endpoints

Masupirdine (SUVN‐502) in combination with donepezil and memantine in moderate Alzheimer's disease: Effect of AD duration since diagnosis and patient’s age on efficacy endpoints

by Nirogi, Ramakrishna, Shinde, Anil K, Benade, Vijay, Subramanian, Ramkumar, Bhyrapuneni, Gopinadh, Ravulu, Jyothsna, Jetta, Satish, Rasheed, Mohammed Abdul, Badange, Rajesh Kumar, Jasti, Venkat
Published in Alzheimer's & dementia (01.12.2020)

Get full text

Journal Article

Masupirdine (SUVN‐502) in combination with donepezil and memantine in moderate Alzheimer's disease: Effect of AD duration since diagnosis and patient’s age on efficacy endpoints: Human/Human trials: Cognitive enhancement

Masupirdine (SUVN‐502) in combination with donepezil and memantine in moderate Alzheimer's disease: Effect of AD duration since diagnosis and patient’s age on efficacy endpoints: Human/Human trials: Cognitive enhancement

by Nirogi, Ramakrishna, Shinde, Anil K, Benade, Vijay, Subramanian, Ramkumar, Bhyrapuneni, Gopinadh, Ravulu, Jyothsna, Jetta, Satish, Rasheed, Mohammed Abdul, Badange, Rajesh Kumar, Jasti, Venkat
Published in Alzheimer's & dementia (01.12.2020)

Get full text

Journal Article

Discovery and Preclinical Characterization of Usmarapride (SUVN-D4010): A Potent, Selective 5-HT 4 Receptor Partial Agonist for the Treatment of Cognitive Deficits Associated with Alzheimer’s Disease

Discovery and Preclinical Characterization of Usmarapride (SUVN-D4010): A Potent, Selective 5-HT 4 Receptor Partial Agonist for the Treatment of Cognitive Deficits Associated with Alzheimer’s Disease

by Nirogi, Ramakrishna, Mohammed, Abdul Rasheed, Shinde, Anil Karbhari, Gagginapally, Shankar Reddy, Kancharla, Durga Malleshwari, Ravella, Srinivasa Rao, Bogaraju, Narsimha, Middekadi, Vanaja Reddy, Subramanian, Ramkumar, Palacharla, Raghava Choudary, Benade, Vijay, Muddana, Nageswararao, Abraham, Renny, Medapati, Rajesh Babu, Thentu, Jagadeesh Babu, Mekala, Venkat Reddy, Petlu, Surendra, Lingavarapu, Bujji Babu, Yarra, Sivasekhar, Kagita, Narendra, Goyal, Vinod Kumar, Pandey, Santosh Kumar, Jasti, Venkat
Published in Journal of medicinal chemistry (12.08.2021)

Get full text

Journal Article

Safety, Tolerability, and Pharmacokinetics of SUVN-G3031, a Novel Histamine-3 Receptor Inverse Agonist for the Treatment of Narcolepsy, in Healthy Human Subjects Following Single and Multiple Oral Doses

Safety, Tolerability, and Pharmacokinetics of SUVN-G3031, a Novel Histamine-3 Receptor Inverse Agonist for the Treatment of Narcolepsy, in Healthy Human Subjects Following Single and Multiple Oral Doses

by Nirogi, Ramakrishna, Mudigonda, Koteshwara, Bhyrapuneni, Gopinadh, Muddana, Nageswara Rao, Shinde, Anil, Goyal, Vinod Kumar, Pandey, Santosh Kumar, Mohammed, Abdul Rasheed, Ravula, Jyothsna, Jetta, Satish, Palacharla, Veera Raghava Chowdary
Published in Clinical drug investigation (01.07.2020)

Get full text

Journal Article

A selective and accurate liquid chromatography-tandem mass spectrometry method for the quantitation of the novel 5-HT 4 receptor partial agonist SUVN-D4010 (Usmarapride) in human plasma and urine

A selective and accurate liquid chromatography-tandem mass spectrometry method for the quantitation of the novel 5-HT 4 receptor partial agonist SUVN-D4010 (Usmarapride) in human plasma and urine

by Nirogi, Ramakrishna, Kalaikadhiban, Ilayaraja, Padala, Naga Surya Prakash, Pantangi, Hanumanth Rao, Chunduru, Prathyusha, Mohammed, Abdul Rasheed
Published in Journal of pharmaceutical and biomedical analysis (20.03.2022)

Get full text

Journal Article

Discovery and Development of 1‑[(2-Bromophenyl)sulfonyl]-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]‑1H‑indole Dimesylate Monohydrate (SUVN-502): A Novel, Potent, Selective and Orally Active Serotonin 6 (5-HT6) Receptor Antagonist for Potential Treatment of Alzheimer’s Disease

Discovery and Development of 1‑[(2-Bromophenyl)sulfonyl]-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]‑1H‑indole Dimesylate Monohydrate (SUVN-502): A Novel, Potent, Selective and Orally Active Serotonin 6 (5-HT6) Receptor Antagonist for Potential Treatment of Alzheimer’s Disease

by Nirogi, Ramakrishna, Shinde, Anil, Kambhampati, Rama Sastry, Mohammed, Abdul Rasheed, Saraf, Sangram Keshari, Badange, Rajesh kumar, Bandyala, Thrinath Reddy, Bhatta, Venugopalarao, Bojja, Kumar, Reballi, Veena, Subramanian, Ramkumar, Benade, Vijay, Palacharla, Raghava Choudary, Bhyrapuneni, Gopinadh, Jayarajan, Pradeep, Goyal, Vinod, Jasti, Venkat
Published in Journal of medicinal chemistry (09.03.2017)

Get full text

Journal Article

Evaluation of metabolism dependent inhibition of CYP2B6 mediated bupropion hydroxylation in human liver microsomes by monoamine oxidase inhibitors and prediction of potential as perpetrators of drug interaction

Evaluation of metabolism dependent inhibition of CYP2B6 mediated bupropion hydroxylation in human liver microsomes by monoamine oxidase inhibitors and prediction of potential as perpetrators of drug interaction

by Nirogi, Ramakrishna, Palacharla, Raghava Choudary, Mohammed, Abdul Rasheed, Manoharan, Arunkumar, Ponnamaneni, Ranjith kumar, Bhyrapuneni, Gopinadh
Published in Chemico-biological interactions (25.03.2015)

Get full text

Journal Article

Safety of 5914 intravitreal ziv-aflibercept injections

Safety of 5914 intravitreal ziv-aflibercept injections

by Singh, Sumit Randhir, Stewart, Michael W, Chattannavar, Goura, Ashraf, Mohammed, Souka, Ahmed, ElDardeery, Mazen, Wadhwa, Neeraj, Sarvaiya, Chintan, Mansour, Ahmad M, Marashi, Ameen, Ramchandani, Suresh, Braimah, Imoro Zeba, Jabbarpoor Bonyadi, Mohammad Hossein, Ramezani, Alireza, Soheilian, Masoud, de Oliveira Dias, João Rafael, de Andrade, Gabriel Costa, Maia, André, Rodrigues, Eduardo Büchele, Farah, Michel Eid, Banker, Alay, Chhablani, Jay
Published in British journal of ophthalmology (01.06.2019)

Get full text

Journal Article

[1]
Prev
1
2
3
4
5
6
7
8
9
10
11
Next
[20]